CRL

Charles River Laboratories International, Inc. · Healthcare · Medical - Diagnostics & Research
$179.31
+0.97 (+0.54%)
Mkt Cap: 8.83B
Key Metrics
MetricValue
P/E RatioN/A
EV/EBITDAN/A
ROEN/A
Gross MarginN/A
Revenue GrowthN/A
FCF Yield5.1%
Dividend YieldN/A
Market Cap8.83B
Volume550.1K
Recent News
Will Charles River (CRL) Beat Estimates Again in Its Next Earnings Report?
zacks.com · 2026-04-14
Massachusetts Financial Services Co. MA Takes Position in Charles River Laboratories International, Inc. $CRL
defenseworld.net · 2026-04-13
Charles River Advances Cardiovascular Health Awareness Through Support of the American Heart Association
businesswire.com · 2026-04-09
Charles River Laboratories International, Inc. (NYSE:CRL) Receives Average Recommendation of “Moderate Buy” from Brokerages
defenseworld.net · 2026-04-08
NYSE Content Update: Join Us and 6,500+ Attendees at Marquee AI Event HumanX
prnewswire.com · 2026-04-06
Allspring Global Investments Holdings LLC Cuts Stock Holdings in Charles River Laboratories International, Inc. $CRL
defenseworld.net · 2026-03-31

Unlock the Full Deep Scan

9 AI agents analyze CRL across earnings, insider flow, macro conditions, corporate strategy, market microstructure, and price action.

Sign Up Free →